title: Eppendorf finalist. Striatal interneurons: causes of or cures for movement disorders?
authors.affiliation: Department of Biological Sciences and the Center for the Neural Basis of Cognition, Carnegie Mellon University, USA.
authors.forename: Aryn
authors.initials: A
authors.lastname: Gittis
mesh_terms: D000218:Adamantane / Q000008:administration & dosage / Q000031:analogs & derivatives; D018663:Adrenergic Agents / Q000633:toxicity; D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use; D003342:Corpus Striatum / Q000187:drug effects / Q000503:physiopathology*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007395:Interneurons / Q000187:drug effects* / Q000502:physiology*; D007980:Levodopa / Q000627:therapeutic use; D051379:Mice; D008822:Mice, Transgenic; D009069:Movement Disorders / Q000188:drug therapy / Q000503:physiopathology; D009434:Neural Pathways / Q000187:drug effects / Q000503:physiopathology; D016627:Oxidopamine / Q000633:toxicity; D020734:Parkinsonian Disorders / Q000188:drug therapy* / Q000503:physiopathology*; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors; D018092:Kainic Acid Receptors / Q000037:antagonists & inhibitors; D017211:Treatment Failure
chemical_list: D000218:Adamantane; D018663:Adrenergic Agents; D000978:Antiparkinson Agents; D004298:Dopamine; D007980:Levodopa; D016627:Oxidopamine; D018091:Receptors, AMPA; D018092:Kainic Acid Receptors; C110702:IEM 1460